Treatment of glossodynia with olanzapine

A 73-year-old white male with a 6-month history of glossodynia, unresponsive to clotrimazole troches, cevimeline, triamcinolone dental paste, paroxetine, and lorazepam presented to the dermatology clinic for consultation. Work-up revealed no oral abnormalities and no underlying systemic disorder. He...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2004-09, Vol.51 (3), p.463-465
Main Authors: Gick, Carrie L., Mirowski, Ginat W., Kennedy, John S., Bymaster, Frank P.
Format: Article
Language:English
Subjects:
Aged
Benzodiazepines - therapeutic use
Biological and medical sciences
Burns - complications
Dermatology
Dysgeusia - etiology
Follow-Up Studies
Glossalgia - drug therapy
Glossalgia - etiology
Humans
Male
Medical sciences
Non tumoral diseases
Otorhinolaryngology. Stomatology
Remission Induction
Serotonin Antagonists - therapeutic use
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 73-year-old white male with a 6-month history of glossodynia, unresponsive to clotrimazole troches, cevimeline, triamcinolone dental paste, paroxetine, and lorazepam presented to the dermatology clinic for consultation. Work-up revealed no oral abnormalities and no underlying systemic disorder. He denied symptoms consistent with a psychiatric disorder. A detailed free amnestic assessment by a board certified Geriatric Psychiatrist (John S. Kennedy, MD) found that the patient was oppressed by the pain. He did not meet the criteria for major depression nor did he have any anxiety disorder or delusions. Because of the presence of dysphoria and anticipatory anxiety secondary to glossodynia, the patient was started on olanzapine. Improvement of pain symptoms were noted within 3 days with full resolution of symptoms at 1- and 3-month follow-ups. Dysphoria and anticipatory anxiety remitted fully upon pain relief.
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2004.02.016